Portfolio Update: Making Moves in a Changing Market
It’s been a few months since our last portfolio update, and we’ve finally got some changes to share with you. Let’s take a closer look at our 50X Master Portfolio and the adjustments we’re making.
Current & Historical Performance
While Bitcoin seems to be doing well, the rest of the market is quite uneven. Since July, Bitcoin has gone up about 15%, while Ethereum has dropped nearly 10%. As a result, our total return is at 13.12%, mainly due to Bitcoin’s performance. However, other holdings are still in the red.
The two main players, Bitcoin and Ethereum, have shown a 72% and 30% increase respectively, which is promising compared to other alt portfolios.
In Profit
Besides Bitcoin, The Graph, Kujira, and Lukso have brought in some profits. Kujira stands out with a 28% profit after Bitcoin.
In Losses
Unfortunately, everything else is facing losses, with Moonbeam down by 53%, Avalanche by 38%, and Polkadot by 34%. Despite this, we’re still confident in Moonbeam’s potential.
Future Portfolio Direction
We’re selling off some slow movers – DOT, AVAX, and FUSE – as we believe they may take longer to recover than other projects. These sales will cover our losses and provide some cash proceeds for reinvestment.
Scenario #1 Bull Trap/Not in a Bull Market Yet
If you believe this is not the beginning of a new bull market due to economic and political uncertainties or the lack of an Alt Season yet, consider buying stablecoins for now.
Scenario #2 Start of a Bull Market
If you think this marks the start of a bull market based on quant analyst Plan B’s Stock to Flow model indicating an upcoming upcycle following Bitcoin halving cycles, consider investing in something promising.
New Buy: INJECTIVE
We’re confident that we’re entering into a new bull market. Following this thesis, we’ve decided to purchase INJECTIVE. This Cosmos-based appchain aligns with our investment criteria and shows potential for growth despite current market conditions.
Last October 28th, we invested $857 to buy 63 INJ at $13.59 each. So far, it’s showing a small profit of $115. With impressive growth over the past year and month (up by 500% and 100% respectively), INJ has proven itself during tough market conditions.